CRISPR screen identifies genes, drug targets to protect against SARS-CoV-2 infection
To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a genome-scale, loss-of-function ...